Shivang Shukla, Abhijeet Ashok Salunke, Maharshi Trivedi, Keval Patel, Shivam Pandya, Ritesh Suthar, Tarun Reddy, Kanika Kapoor, Poojitha Yala, Geetha Krishna, Nandlal Bharwani, Shashank Pandya
BACKGROUND: Ewing's sarcoma is highly aggressive bone tumor having predilection for younger age groups with t (11,22) translocation, recombines the FLI-1 and EWS genes on chromosome 22. This disease requires multi-disciplinary treatment withneo-adjuvant chemotherapy followed by surgery or radiotherapy and adjuvant chemotherapy. This study was aimed to assess the demographic distribution, clinical behaviour and oncological outcome of Ewings Sarcoma involving upper extremity. METHODS: From 2015 to 2022, 45 patients of upper extremity Ewing's sarcoma underwent treatment at a territory cancer centre...
March 2024: Journal of Orthopaedics